Yi Gawon, Hong Suk Ho, Son Jihwan, Yoo Jihye, Park Changhee, Choi Yongdoo, Koo Heebeom
Department of Medical Lifescience, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Biomarker Branch, National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea.
Quant Imaging Med Surg. 2018 May;8(4):433-443. doi: 10.21037/qims.2018.05.04.
This review summarizes recent advances in the development of nanoparticles (NPs) for efficient photodynamic therapy (PDT), particularly the development and application of various NPs based on organic and inorganic materials. PubMed database was used for literature search with the terms including NP, nanomedicine, PDT, photosensitizer (PSs), and drug delivery. For successful PDT, it is essential to deliver PSs to target disease sites. A number of NPs have been developed and tested as the carriers for both imaging and therapy, an approach termed "nanomedicine". Many studies of NP carriers showed increased water solubility and stability of PSs for injection, and these NP carriers provided benefits including longer circulation in blood and higher accumulation of PSs at disease sites. This review describes new techniques in PDT such as aggregation-induced emission (AIE) and luminescence-based PDT, and provides insights on NPs and PDT for biomedical researchers working to develop or apply NPs in efficient PDT.
本综述总结了用于高效光动力疗法(PDT)的纳米颗粒(NP)开发的最新进展,特别是基于有机和无机材料的各种NP的开发与应用。使用PubMed数据库进行文献检索,检索词包括NP、纳米医学、PDT、光敏剂(PS)和药物递送。为成功进行PDT,将PS递送至靶疾病部位至关重要。已开发并测试了多种NP作为成像和治疗的载体,这种方法称为“纳米医学”。许多关于NP载体的研究表明,PS的水溶性和稳定性增加,便于注射,并且这些NP载体具有诸多益处,包括在血液中循环时间更长以及PS在疾病部位的积累量更高。本综述描述了PDT中的新技术,如聚集诱导发光(AIE)和基于发光的PDT,并为致力于在高效PDT中开发或应用NP的生物医学研究人员提供了有关NP和PDT的见解。